Trial Profile
A randomized, parallel trial of atomoxetine on driving performance in real traffic, driving related neuropsychological performance test and self evaluation of driving in adult patients with attention deficit hyperactivity disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 03 Dec 2015 New trial record